Free Trial
OTCMKTS:TEAR

TearLab (TEAR) Stock Price, News & Analysis

TearLab logo
$0.06 0.00 (-1.86%)
As of 07/9/2020

About TearLab Stock (OTCMKTS:TEAR)

Key Stats

Today's Range
$0.06
▼
$0.06
50-Day Range
$0.06
▼
$0.06
52-Week Range
$0.02
▼
$0.22
Volume
20,200 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TearLab Corporation was a medical diagnostics company focused on eye-care testing and the evaluation of dry eye disease. Its primary product was the TearLab Osmolarity System, a point-of-care diagnostic platform designed to measure tear-film osmolarity, an indicator used by eye-care professionals when assessing ocular surface health and dry eye.

The company’s technology was intended for use in ophthalmology and optometry practices, providing rapid testing near the patient rather than relying solely on centralized laboratory analysis. TearLab marketed its products internationally through direct sales and distribution arrangements, although publicly available information about its current operations and geographic footprint is limited.

TearLab’s securities have historically traded over the counter under the symbol TEAR. The company’s operating history is associated primarily with the development and commercialization of its tear-osmolarity testing platform; reliable current information about its leadership and ongoing corporate activities is not readily available.

AI Generated. May Contain Errors.

Receive TEAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TEAR Stock News Headlines

Harrow Announces New Appointments to its Board of Directors
STRATA Skin Science Announces Leadership Change
Trump, Schiff and Dalio all point to the same warning sign
In 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't made whole until age 85. Today, the national debt sits at 38.86 trillion dollars, a level the market has never faced before. Economists including Peter Schiff and Ray Dalio point to a classic bubble forming.tc pixel
Lawrence schools on 'good footing' financially
Pathway Makes Four Senior Promotions
See More Headlines

TEAR Stock Analysis - Frequently Asked Questions

TearLab's stock was trading at $0.0579 at the beginning of the year. Since then, TEAR stock has increased by 0.0% and is now trading at $0.0579.

TearLab Corporation (OTCMKTS:TEAR) posted its quarterly earnings data on Thursday, August, 8th. The medical research company reported ($0.10) EPS for the quarter. The medical research company had revenue of $5.85 million for the quarter.

Shares of TearLab reverse split before market open on Friday, February 24th 2017.The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 23rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that TearLab investors own include SCYNEXIS (SCYX), Vislink Technologies (XGTI), Biopharmx (BPMX), Merck & Co., Inc. (MRK), NIKE (NKE), Protalix BioTherapeutics (PLX) and Trevena (TRVN).

Company Calendar

Today
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:TEAR
Previous Symbol
NASDAQ:TEAR
CIK
1299139
Employees
34
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (OTCMKTS:TEAR) was last updated on 7/9/2020 by MarketBeat.com Staff.
From Our Partners